SHRIRAMFINNSEShriram Finance LimitedMediumNeutral
Announced Mon, 4 May · 16:27 IST

Shriram Finance Limited has informed the Exchange about Transcript

Analyst Day Multiyear TargetsCfo Debt Reduction RoadmapInvestor Communications View source PDF

SHRIRAMFIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.8%1-day move
₹961.00
prior close
₹955.65
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.5-1.6-1.5-0.8+4.8+5.4+4.4+1.7-2.8-2.5-0.8-4.0+10.8
Up moveDown movePending
AI summary

Shriram Finance reported strong Q4 FY26 results with PAT growth of 40.86% YoY to ₹3,013.57 crore. AUM grew 14.85% YoY to ₹3,02,274 crore. NIM improved to 8.61% from 8.25% in Q4 FY25, while cost-to-income ratio improved significantly to 25.32%. Gross Stage 3 asset quality remained stable at 4.58%. The company completed a landmark ₹39,618 crore equity infusion from MUFG Bank, giving them 20% stake and boosting capital adequacy to 34%. Management guided for 18% AUM growth in FY27, projecting CV at 15-18%, PV above 20%, and MSME at 13-15%. NIM is guided conservatively at 8.5% with some benefit from lower cost of funds likely to be passed to customers. The company highlighted concerns about below-average monsoon forecast and geopolitical risks potentially impacting Q1 FY27, while remaining cautiously optimistic on growth.

Likely market impact

The strong PAT growth and massive capital infusion from MUFG significantly strengthen Shriram's balance sheet and growth prospects. The 18% AUM growth guidance with stable margins indicates confidence, though Q1 FY27 may face headwinds from monsoon uncertainties and geopolitical tensions. The AAA rating upgrade post-infusion should lower borrowing costs going forward.